Geneva Capital Management LLC trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 5.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 743,520 shares of the company's stock after selling 44,958 shares during the period. Geneva Capital Management LLC owned approximately 0.44% of Option Care Health worth $17,250,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of OPCH. Cornerstone Investment Partners LLC increased its stake in Option Care Health by 3.6% during the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after buying an additional 333 shares during the period. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares in the last quarter. Assetmark Inc. increased its stake in shares of Option Care Health by 2.0% during the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after acquiring an additional 487 shares during the period. Lindenwold Advisors INC raised its holdings in Option Care Health by 5.4% during the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company's stock worth $299,000 after purchasing an additional 489 shares in the last quarter. Finally, Pacer Advisors Inc. lifted its position in Option Care Health by 2.2% in the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock worth $591,000 after purchasing an additional 537 shares during the period. 98.05% of the stock is currently owned by institutional investors.
Option Care Health Trading Down 1.9 %
Shares of OPCH traded down $0.63 during midday trading on Monday, hitting $33.38. The stock had a trading volume of 2,889,089 shares, compared to its average volume of 1,601,487. The business has a 50-day simple moving average of $29.83 and a two-hundred day simple moving average of $28.16. The firm has a market cap of $5.52 billion, a P/E ratio of 28.05, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.85.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on OPCH shares. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research boosted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and upped their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. UBS Group began coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective on the stock. Finally, JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $33.00.
Get Our Latest Research Report on OPCH
Insider Activity at Option Care Health
In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is owned by insiders.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
